GSA Capital Partners’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-14,150
| Closed | -$58K | – | 1965 |
|
|
2022
Q1 | $58K | Buy |
+14,150
| New | +$51.3K | 0.01% | 1332 |
|
|
2021
Q4 | – | Sell |
-256,622
| Closed | -$934K | – | 1956 |
|
|
2021
Q3 | $934K | Buy |
256,622
+16,319
| +7% | +$66K | 0.1% | 337 |
|
|
2021
Q2 | $1.05M | Buy |
240,303
+141,683
| +144% | +$577K | 0.12% | 230 |
|
|
2021
Q1 | $405K | Buy |
98,620
+22,894
| +30% | +$99.2K | 0.07% | 464 |
|
|
2020
Q4 | $302K | Buy |
75,726
+36,307
| +92% | +$117K | 0.05% | 732 |
|
|
2020
Q3 | $106K | Buy |
+39,419
| New | +$109K | 0.02% | 1127 |
|
|
2020
Q2 | – | Sell |
-357,789
| Closed | -$844K | – | 1273 |
|
|
2020
Q1 | $844K | Buy |
357,789
+338,905
| +1,795% | +$1.15M | 0.21% | 36 |
|
|
2019
Q4 | $89K | Sell |
18,884
-13,612
| -42% | -$55.7K | 0.01% | 1348 |
|
|
2019
Q3 | $109K | Buy |
+32,496
| New | +$107K | 0.01% | 1267 |
|
|
2019
Q1 | – | Sell |
-18,903
| Closed | -$51K | – | 1781 |
|
|
2018
Q4 | $51K | Buy |
+18,903
| New | +$62.3K | 0.01% | 1266 |
|
|
2018
Q2 | – | Sell |
-233,300
| Closed | -$513K | – | 2022 |
|
|
2018
Q1 | $513K | Buy |
233,300
+4,800
| +2% | +$10.8K | 0.03% | 1046 |
|
|
2017
Q4 | $455K | Buy |
228,500
+46,425
| +25% | +$101K | 0.03% | 983 |
|
|
2017
Q3 | $590K | Sell |
182,075
-20,085
| -10% | -$62K | 0.04% | 866 |
|
|
2017
Q2 | $651K | Buy |
+202,160
| New | +$573K | 0.04% | 849 |
|
|
2015
Q2 | – | Sell |
-102,316
| Closed | -$277K | – | 2256 |
|
|
2015
Q1 | $277K | Buy |
102,316
+63,300
| +162% | +$161K | 0.01% | 1760 |
|
|
2014
Q4 | $100K | Sell |
39,016
-8,984
| -19% | -$20.2K | 0.01% | 1588 |
|
|
2014
Q3 | $88K | Buy |
+48,000
| New | +$105K | ﹤0.01% | 1631 |
|
Other funds holding ATRS
GSA Capital Partners's ATRS Position: Q2 2022 in Review
GSA Capital Partners sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 14,150 shares — an estimated $58K sold.
GSA Capital Partners first reported a position in ATRS in Q3 2014 and held it in 17 quarters. The position peaked at $1.05M in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- GSA Capital Partners reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- GSA Capital Partners sold 14,150 Antares Pharma, Inc. shares in Q2 2022, an estimated $58K.
- GSA Capital Partners first reported a position in Antares Pharma, Inc. in Q3 2014 and held it in 17 quarters.
- GSA Capital Partners's Antares Pharma, Inc. position peaked at $1.05M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.